Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRX) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001581178 · EPRX · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001581178 · Updated hourly · Not investment advice
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) has submitted 109 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001581178, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Eupraxia Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Eupraxia Pharmaceuticals Inc. 10-K was filed on — for fiscal year ending —. Historical EPRX 10-K annual reports are available from 2013 through —.
Investors researching Eupraxia Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
EPRX SEC Filings · 8 questionsEupraxia Pharmaceuticals Inc. (EPRX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 109 filings and access original documents at no cost. Eupraxia Pharmaceuticals Inc.'s CIK is 0001581178.